← Leaderboards
Hooman Kamel
Yale University
$18,001,522
Attributed
$49,976,004
Total exposure
8
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $11.4M · FY2013–25$20M$15M$10M$5M$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$49,976,004 · 8
By mechanism
U01$38,887,465 · 2
R01$10,151,124 · 5
K23$937,415 · 1
Top collaborators
- Ajay Gupta12 shared
- Joseph Paul Broderick5 shared
- Wt Longstreth5 shared
- Caitlyn N Meinzer5 shared
- Kevin Navin Sheth5 shared
- David L Tirschwell5 shared
- Mitchell S Elkind4 shared
- Thanh D Nguyen4 shared
Most similar at Yale University
Same institution · by research overlap
- Adam H. De Havenon$5,725,083
- Richa Sharma$767,086
- Robin A De Graaf$11,435,218
- Carlos Fernandez Hernando$14,750,691
- Emily Gilmore$1,161,432
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeIschemic StrokeStroke PreventionHigh RiskRisk FactorsMissionAtrial FibrillationHemorrhageClinical TrialsStroke RiskSourceMagnetic Resonance ImagingHeart AtriumCardiacIncidenceFosteringHeart RhythmLeadScreeningAnticoagulantsArteriesPublic HealthEnrollmentRecurrence
Grant awards (31)
CAROTID-MAP Carotid Atherosclerotic Risk Assessment Through Imaging andPrediction$771,485
R01 · FY2025 · HL
Quantitative Cerebral Oxygen Metabolic Imaging of Acute Ischemic Stroke$662,533
R01 · FY2025 · NS
Quantitative Susceptibility Mapping for Stroke Risk Prediction of Vulnerable Carotid Plaques$604,489
R01 · FY2025 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$4,840,791
U01 · FY2024 · NS
Quantitative Cerebral Oxygen Metabolic Imaging of Acute Ischemic Stroke$666,530
R01 · FY2024 · NS
Quantitative Susceptibility Mapping for Stroke Risk Prediction of Vulnerable Carotid Plaques$661,408
R01 · FY2024 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$4,270,266
U01 · FY2023 · NS
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)$693,913
R01 · FY2023 · HL · contact PI
Quantitative Susceptibility Mapping for Stroke Risk Prediction of Vulnerable Carotid Plaques$689,032
R01 · FY2023 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$2,310,548
U01 · FY2022 · NS
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)$796,696
R01 · FY2022 · HL
Quantitative susceptibility mapping for stroke risk prediction of vulnerable carotid plaques$697,823
R01 · FY2022 · NS
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$1,790,846
U01 · FY2021 · NS
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)$823,628
R01 · FY2021 · HL
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,861,083
U01 · FY2020 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$3,246,233
U01 · FY2020 · NS
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)$815,480
R01 · FY2020 · HL
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$502,754
U01 · FY2020 · NS
Anticoagulation in ICH Survivors for Prevention and Recovery (ASPIRE)$4,032,209
U01 · FY2019 · NS
MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER)$801,993
R01 · FY2019 · HL
Left Atrial abNormality, ThromboEmbolism, and Race: Novel risk factors for stroke (LANTERN)$287,673
R01 · FY2019 · NS · contact PI
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$6,959,908
U01 · FY2018 · NS
Left Atrial abNormality, ThromboEmbolism, and Race: Novel risk factors for stroke (LANTERN)$329,398
R01 · FY2018 · NS · contact PI
AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenicstroke (ARCADIA)$4,072,827
U01 · FY2017 · NS
Left Atrial abNormality, ThromboEmbolism, and Race: Novel risk factors for stroke (LANTERN)$416,998
R01 · FY2017 · NS · contact PI
Atrial Fibrillation Precursors May Be Novel Stroke Risk Factors$187,483
K23 · FY2017 · NS · contact PI
Left Atrial abNormality, ThromboEmbolism, and Race: Novel risk factors for stroke (LANTERN)$432,045
R01 · FY2016 · NS · contact PI
Atrial Fibrillation Precursors May Be Novel Stroke Risk Factors$187,483
K23 · FY2016 · NS · contact PI
Atrial Fibrillation Precursors May Be Novel Stroke Risk Factors$187,483
K23 · FY2015 · NS · contact PI
Atrial Fibrillation Precursors May Be Novel Stroke Risk Factors$187,483
K23 · FY2014 · NS · contact PI
Atrial Fibrillation Precursors May Be Novel Stroke Risk Factors$187,483
K23 · FY2013 · NS · contact PI